{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:19:34Z","timestamp":1790965174651,"version":"4.1.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T00:00:00Z","timestamp":1395705600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s11883-014-0409-1","type":"journal-article","created":{"date-parts":[[2014,3,24]],"date-time":"2014-03-24T01:19:51Z","timestamp":1395623991000},"source":"Crossref","is-referenced-by-count":93,"title":["Adiposopathy, \u201cSick Fat,\u201d Ockham\u2019s Razor, and Resolution of the Obesity Paradox"],"prefix":"10.1007","volume":"16","author":[{"given":"Harold","family":"Bays","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,25]]},"reference":[{"key":"409_CR1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/014107689709000108","volume":"90","author":"AR Walker","year":"1997","unstructured":"Walker AR, Sareli P. Coronary heart disease: outlook for Africa. J R Soc Med. 1997;90:23\u20137.","journal-title":"J R Soc Med"},{"key":"409_CR2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/ajcn\/73.2.353","volume":"73","author":"AR Walker","year":"2001","unstructured":"Walker AR. Are health and ill-health lessons from hunter-gatherers currently relevant? Am J Clin Nutr. 2001;73:353\u20136.","journal-title":"Am J Clin Nutr"},{"key":"409_CR3","doi-asserted-by":"crossref","first-page":"e40503","DOI":"10.1371\/journal.pone.0040503","volume":"7","author":"H Pontzer","year":"2012","unstructured":"Pontzer H, Raichlen DA, Wood BM, Mabulla AZ, Racette SB, Marlowe FW. Hunter-gatherer energetics and human obesity. PLoS One. 2012;7:e40503.","journal-title":"PLoS One"},{"key":"409_CR4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1440-1681.1991.tb01412.x","volume":"18","author":"K O'Dea","year":"1991","unstructured":"O'Dea K. Cardiovascular disease risk factors in Australian aborigines. Clin Exp Pharmacol Physiol. 1991;18:85\u20138.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"409_CR5","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/j.jacc.2004.03.046","volume":"43","author":"JH O'Keefe Jr","year":"2004","unstructured":"O'Keefe Jr JH, Cordain L, Harris WH, Moe RM, Vogel R. Optimal low-density lipoprotein is 50 to 70\u00a0mg\/dl: lower is better and physiologically normal. J Am Coll Cardiol. 2004;43:2142\u20136.","journal-title":"J Am Coll Cardiol"},{"key":"409_CR6","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.amjmed.2008.10.015","volume":"122","author":"HE Bays","year":"2009","unstructured":"Bays HE. \u201cSick fat,\u201d metabolic disease, and atherosclerosis. Am J Med. 2009;122:S26\u201337.","journal-title":"Am J Med"},{"key":"409_CR7","unstructured":"World Health Organization. Obesity and overweight. 2003. http:\/\/www.who.int\/dietphysicalactivity\/media\/en\/gsfs_obesity.pdf . Accessed 17 Jan 2014."},{"key":"409_CR8","unstructured":"Centers for Disease Control and Prevention. Obesity and overweight. http:\/\/www.cdc.gov\/nchs\/fastats\/overwt.htm (2013). Accessed 17 Jan 2014."},{"key":"409_CR9","unstructured":"World Health Organization. Cardiovascular diseases. http:\/\/www.who.int\/mediacentre\/factsheets\/fs317\/en\/ (2013). Accessed 17 Jan 2014."},{"key":"409_CR10","doi-asserted-by":"crossref","first-page":"f1050","DOI":"10.1136\/bmj.f1050","volume":"346","author":"D Haslam","year":"2013","unstructured":"Haslam D. Letter to the Editor. Re: The science of obesity: what do we really know about what makes us fat? An essay by Gary Taubes. Br Med J. 2013;346:f1050.","journal-title":"Br Med J"},{"key":"409_CR11","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/sj.ijo.0802268","volume":"27","author":"G Enzi","year":"2003","unstructured":"Enzi G, Busetto L, Inelmen EM, Coin A, Sergi G. Historical perspective: visceral obesity and related comorbidity in Joannes Baptista Morgagni\u2019s \u2018De sedibus et causis morborum per anatomen indagata\u2019. Int J Obes Relat Metab Disord. 2003;27:534\u20135.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"409_CR12","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1681\/ASN.2007040522","volume":"18","author":"E Ritz","year":"2007","unstructured":"Ritz E. Metabolic syndrome - what we know and what we don\u2019t know. J Am Soc Nephrol. 2007;18:1619\u201323.","journal-title":"J Am Soc Nephrol"},{"key":"409_CR13","first-page":"339","volume":"55","author":"J Vague","year":"1947","unstructured":"Vague J. La differenciation sexuelle, facteur determinant des formes de l\u2019obesite. Presse Med. 1947;55:339.","journal-title":"Presse Med"},{"key":"409_CR14","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.jacc.2011.02.038","volume":"57","author":"HE Bays","year":"2011","unstructured":"Bays HE. Adiposopathy is \u201csick fat\u201d a cardiovascular disease? J Am Coll Cardiol. 2011;57:2461\u201373. This is an in-depth review of adiposopathy and CVD.","journal-title":"J Am Coll Cardiol"},{"key":"409_CR15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1517\/14796678.1.1.39","volume":"1","author":"H Bays","year":"2005","unstructured":"Bays H, Abate N, Chandalia M. Adiposopathy: sick fat causes high blood sugar, high blood pressure and dyslipidemia. Futur Cardiol. 2005;1:39\u201359.","journal-title":"Futur Cardiol"},{"key":"409_CR16","first-page":"124","volume":"3","author":"GM Reaven","year":"2001","unstructured":"Reaven GM. Syndrome X: a short history. Ochsner J. 2001;3:124\u20135.","journal-title":"Ochsner J"},{"key":"409_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.hco.0000200416.65370.a0","volume":"21","author":"SM Grundy","year":"2006","unstructured":"Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol. 2006;21:1\u20136.","journal-title":"Curr Opin Cardiol"},{"key":"409_CR18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","volume":"109","author":"SM Grundy","year":"2004","unstructured":"Grundy SM, Brewer Jr HB, Cleeman JI, Smith Jr SC, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433\u20138.","journal-title":"Circulation"},{"key":"409_CR19","unstructured":"Alberti G, Zimmet P, Shaw J, Grundy S. The International Diabetes Federation consensus worldwide definition of the metabolic syndrome. 2006. https:\/\/www.idf.org\/webdata\/docs\/IDF_Meta_def_final.pdf . Accessed 31 Jan 2014."},{"key":"409_CR20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1586\/14779072.6.3.343","volume":"6","author":"HE Bays","year":"2008","unstructured":"Bays HE, Gonzalez-Campoy JM, Bray GA, Kitabchi AE, Bergman DA, Schorr AB, et al. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther. 2008;6:343\u201368.","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"409_CR21","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2337\/diacare.28.9.2289","volume":"28","author":"R Kahn","year":"2005","unstructured":"Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005;28:2289\u2013304.","journal-title":"Diabetes Care"},{"key":"409_CR22","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2337\/diab.44.4.369","volume":"44","author":"MP Stern","year":"1995","unstructured":"Stern MP. Diabetes and cardiovascular disease. The \u201ccommon soil\u201d hypothesis. Diabetes. 1995;44:369\u201374.","journal-title":"Diabetes"},{"key":"409_CR23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2337\/diacare.29.01.06.dc05-0862","volume":"29","author":"M Pladevall","year":"2006","unstructured":"Pladevall M, Singal B, Williams LK, Brotons C, Guyer H, Sadurni J, et al. A single factor underlies the metabolic syndrome: a confirmatory factor analysis. Diabetes Care. 2006;29:113\u201322.","journal-title":"Diabetes Care"},{"key":"409_CR24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-0029-1192044","volume":"117","author":"M Bluher","year":"2009","unstructured":"Bluher M. Adipose tissue dysfunction in obesity. Exp Clin Endocrinol Diabetes. 2009;117:241\u201350.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"409_CR25","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/oby.2004.151","volume":"12","author":"HE Bays","year":"2004","unstructured":"Bays HE. Current and investigational antiobesity agents and obesity therapeutic treatment targets. Obes Res. 2004;12:1197\u2013211.","journal-title":"Obes Res"},{"key":"409_CR26","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1111\/j.1742-1241.2008.01848.x","volume":"62","author":"HE Bays","year":"2008","unstructured":"Bays HE, Gonzalez-Campoy JM, Henry RR, Bergman DA, Kitabchi AE, Schorr AB, et al. Is adiposopathy (sick fat) an endocrine disease? Int J Clin Pract. 2008;62:1474\u201383.","journal-title":"Int J Clin Pract"},{"key":"409_CR27","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jacl.2013.04.001","volume":"7","author":"HE Bays","year":"2013","unstructured":"Bays HE, Toth PP, Kris-Etherton PM, Abate N, Aronne LJ, Brown WV, et al. Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association. J Clin Lipidol. 2013;7:304\u201383. This is an in-depth review of adiposopathy and dyslipidemia.","journal-title":"J Clin Lipidol"},{"key":"409_CR28","doi-asserted-by":"crossref","first-page":"4B","DOI":"10.1016\/j.amjcard.2012.08.029","volume":"110","author":"HE Bays","year":"2012","unstructured":"Bays HE. Adiposopathy, diabetes mellitus, and primary prevention of atherosclerotic coronary artery disease: treating \u201csick fat\u201d through improving fat function with antidiabetes therapies. Am J Cardiol. 2012;110:4B\u201312B. This is an in-depth review of adiposopathy and diabetes mellitus.","journal-title":"Am J Cardiol"},{"key":"409_CR29","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11684-013-0288-9","volume":"7","author":"J Yang","year":"2013","unstructured":"Yang J, Kang J, Guan Y. The mechanisms linking adiposopathy to type 2 diabetes. Front Med. 2013;7:433\u201344.","journal-title":"Front Med"},{"key":"409_CR30","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/HCO.0b013e3283642a33","volume":"28","author":"S Appachi","year":"2013","unstructured":"Appachi S, Kashyap SR. \u2018Adiposopathy\u2019 and cardiovascular disease: the benefits of bariatric surgery. Curr Opin Cardiol. 2013;28:540\u20136.","journal-title":"Curr Opin Cardiol"},{"key":"409_CR31","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.1742-1241.2009.02151.x","volume":"63","author":"HE Bays","year":"2009","unstructured":"Bays HE, Laferrere B, Dixon J, Aronne L, Gonzalez-Campoy JM, Apovian C, et al. Adiposopathy and bariatric surgery: is \u2018sick fat\u2019 a surgical disease? Int J Clin Pract. 2009;63:1285\u2013300.","journal-title":"Int J Clin Pract"},{"key":"409_CR32","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.metabol.2013.06.004","volume":"62","author":"J Voorde Van de","year":"2013","unstructured":"Van de Voorde J, Pauwels B, Boydens C, Decaluwe K. Adipocytokines in relation to cardiovascular disease. Metabolism. 2013;62:1513\u201321.","journal-title":"Metabolism"},{"key":"409_CR33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/2045-709X-21-15","volume":"21","author":"DR Seaman","year":"2013","unstructured":"Seaman DR. Body mass index and musculoskeletal pain: is there a connection? Chiropr Man Ther. 2013;21:15.","journal-title":"Chiropr Man Ther"},{"key":"409_CR34","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.avsg.2012.07.017","volume":"27","author":"CR Mauro","year":"2013","unstructured":"Mauro CR, Nguyen BT, Yu P, Tao M, Gao I, Seidman MA, et al. Inflammatory \u201cadiposopathy\u201d in major amputation patients. Ann Vasc Surg. 2013;27:346\u201352.","journal-title":"Ann Vasc Surg"},{"key":"409_CR35","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.amjsurg.2012.07.032","volume":"206","author":"CR Mauro","year":"2013","unstructured":"Mauro CR, Ilonzo G, Nguyen BT, Yu P, Tao M, Gao I, et al. Attenuated adiposopathy in perivascular adipose tissue compared with subcutaneous human adipose tissue. Am J Surg. 2013;206:241\u20134.","journal-title":"Am J Surg"},{"key":"409_CR36","doi-asserted-by":"crossref","first-page":"E392","DOI":"10.1152\/ajpendo.00398.2012","volume":"304","author":"JK Pepping","year":"2013","unstructured":"Pepping JK, Freeman LR, Gupta S, Keller JN, Bruce-Keller AJ. NOX2 deficiency attenuates markers of adiposopathy and brain injury induced by high-fat diet. Am J Physiol Endocrinol Metab. 2013;304:E392\u2013404.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"409_CR37","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1586\/erc.12.47","volume":"10","author":"L Duntas","year":"2012","unstructured":"Duntas L, Micic D. Adiposopathy and thyroid disease: tracing the pathway to cardiovascular risk. Expert Rev Cardiovasc Ther. 2012;10:797\u2013803.","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"409_CR38","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1586\/erc.09.123","volume":"7","author":"HE Bays","year":"2009","unstructured":"Bays HE. Lorcaserin and adiposopathy: 5-HT2c agonism as a treatment for \u2018sick fat\u2019 and metabolic disease. Expert Rev Cardiovasc Ther. 2009;7:1429\u201345.","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"409_CR39","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1575-0922(09)72710-X","volume":"56","author":"G Medina-Gomez","year":"2009","unstructured":"Medina-Gomez G, Vidal-Puig A. Tejido adiposo como diana terap\u00e9utica en la obesidad. Endocrinol Nutr. 2009;56:404\u201311.","journal-title":"Endocrinol Nutr"},{"issue":"3","key":"409_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP13155.GL","volume":"19","author":"JM Gonzalez-Campoy","year":"2013","unstructured":"Gonzalez-Campoy JM, St Jeor ST, Castorino K, Ebrahim A, Hurley D, Jovanovic L, et al. Clinical practice guidelines for healthy eating for the prevention and treatment of metabolic and endocrine diseases in adults: cosponsored by the American Association of Clinical Endocrinologists\/the American College of Endocrinology and the Obesity Society. Endocr Pract. 2013;19(3):1\u201382.","journal-title":"Endocr Pract"},{"key":"409_CR41","unstructured":"Seger JC, Horn HD, Westman EC, Lindquist R, Scinta W, Richardson LA et al. Obesity Algorithm, presented by the American Society of Bariatric Physicians. 2013\u20132014. http:\/\/www.asbp.org\/images\/ADV-COPY_ASBPObeistyAlgorithmOctober2013.pdf . Accessed 31 Jan 2014. This is a comprehensive algorithm in obesity assessment and management."},{"key":"409_CR42","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1586\/14779072.3.3.393","volume":"3","author":"H Bays","year":"2005","unstructured":"Bays H. Adiposopathy, metabolic syndrome, quantum physics, general relativity, chaos and the theory of everything. Expert Rev Cardiovasc Ther. 2005;3:393\u2013404.","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"409_CR43","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.lfs.2013.08.016","volume":"93","author":"SJ Hur","year":"2013","unstructured":"Hur SJ, Kim DH, Chun SC, Lee SK. Effect of adenovirus and influenza virus infection on obesity. Life Sci. 2013;93:531\u20135.","journal-title":"Life Sci"},{"key":"409_CR44","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.mam.2012.11.001","volume":"34","author":"J Shen","year":"2013","unstructured":"Shen J, Obin MS, Zhao L. The gut microbiota, obesity and insulin resistance. Mol Aspects Med. 2013;34:39\u201358.","journal-title":"Mol Aspects Med"},{"key":"409_CR45","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1001\/jama.2013.4851","volume":"309","author":"M Maggard-Gibbons","year":"2013","unstructured":"Maggard-Gibbons M, Maglione M, Livhits M, Ewing B, Maher AR, Hu J, et al. Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes: a systematic review. JAMA. 2013;309:2250\u201361.","journal-title":"JAMA"},{"key":"409_CR46","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1038\/oby.2010.90","volume":"18","author":"F Magkos","year":"2010","unstructured":"Magkos F, Fabbrini E, Mohammed BS, Patterson BW, Klein S. Increased whole-body adiposity without a concomitant increase in liver fat is not associated with augmented metabolic dysfunction. Obesity (Silver Spring). 2010;18:1510\u20135.","journal-title":"Obesity (Silver Spring)"},{"key":"409_CR47","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1038\/oby.2009.454","volume":"18","author":"L Perreault","year":"2010","unstructured":"Perreault L, Bergman BC, Hunerdosse DM, Playdon MC, Eckel RH. Inflexibility in intramuscular triglyceride fractional synthesis distinguishes prediabetes from obesity in humans. Obesity (Silver Spring). 2010;18:1524\u201331.","journal-title":"Obesity (Silver Spring)"},{"key":"409_CR48","doi-asserted-by":"crossref","first-page":"292","DOI":"10.5664\/jcsm.27829","volume":"6","author":"DE McCarty","year":"2010","unstructured":"McCarty DE. Beyond Ockham\u2019s razor: redefining problem-solving in clinical sleep medicine using a \u201cfive-finger\u201d approach. J Clin Sleep Med. 2010;6:292\u20136.","journal-title":"J Clin Sleep Med"},{"key":"409_CR49","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1089\/met.2009.0089","volume":"8","author":"HE Bays","year":"2010","unstructured":"Bays HE, Fox KM, Grandy S. Anthropometric measurements and diabetes mellitus: clues to the \u201cpathogenic\u201d and \u201cprotective\u201d potential of adipose tissue. Metab Syndr Relat Disord. 2010;8:307\u201315.","journal-title":"Metab Syndr Relat Disord"},{"issue":"Suppl 4","key":"409_CR50","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1038\/sj.ijo.0802853","volume":"28","author":"L Heilbronn","year":"2004","unstructured":"Heilbronn L, Smith SR, Ravussin E. Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus. Int J Obes Relat Metab Disord. 2004;28 Suppl 4:S12\u201321.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"409_CR51","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3390\/nu5051544","volume":"5","author":"M Gaggini","year":"2013","unstructured":"Gaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E, Gastaldelli A. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients. 2013;5:1544\u201360.","journal-title":"Nutrients"},{"key":"409_CR52","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cmet.2010.11.016","volume":"12","author":"WC Stanley","year":"2010","unstructured":"Stanley WC, Recchia FA. Lipotoxicity and the development of heart failure: moving from mouse to man. Cell Metab. 2010;12:555\u20136.","journal-title":"Cell Metab"},{"key":"409_CR53","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijcard.2013.08.077","volume":"169","author":"S Lim","year":"2013","unstructured":"Lim S, Meigs JB. Ectopic fat and cardiometabolic and vascular risk. Int J Cardiol. 2013;169:166\u201376.","journal-title":"Int J Cardiol"},{"key":"409_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2840-5-1","volume":"5","author":"AR Baker","year":"2006","unstructured":"Baker AR, Silva NF, Quinn DW, Harte AL, Pagano D, Bonser RS, et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol. 2006;5:1.","journal-title":"Cardiovasc Diabetol"},{"key":"409_CR55","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1161\/01.CIR.0000099542.57313.C5","volume":"108","author":"T Mazurek","year":"2003","unstructured":"Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003;108:2460\u20136.","journal-title":"Circulation"},{"key":"409_CR56","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/oby.20181","volume":"21","author":"L Landsberg","year":"2013","unstructured":"Landsberg L, Aronne LJ, Beilin LJ, Burke V, Igel LI, Lloyd-Jones D, et al. Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment\u2014a position paper of the Obesity Society and the American Society of Hypertension. Obesity (Silver Spring). 2013;21:8\u201324. This is an in-depth review of obesity and hypertension.","journal-title":"Obesity (Silver Spring)"},{"key":"409_CR57","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000317641","volume":"57","author":"K Chen","year":"2010","unstructured":"Chen K, Xie Y, Hu P, Zhao S, Mo Z. Multiple symmetric lipomatosis: substantial subcutaneous adipose tissue accumulation did not induce glucose and lipid metabolism dysfunction. Ann Nutr Metab. 2010;57:68\u201373.","journal-title":"Ann Nutr Metab"},{"key":"409_CR58","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.biocel.2011.03.002","volume":"43","author":"C Vigouroux","year":"2011","unstructured":"Vigouroux C, Caron-Debarle M, Le Dour C, Magre J, Capeau J. Molecular mechanisms of human lipodystrophies: from adipocyte lipid droplet to oxidative stress and lipotoxicity. Int J Biochem Cell Biol. 2011;43:862\u201376.","journal-title":"Int J Biochem Cell Biol"},{"key":"409_CR59","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MOL.0b013e32832d4a33","volume":"20","author":"V Simha","year":"2009","unstructured":"Simha V, Garg A. Inherited lipodystrophies and hypertriglyceridemia. Curr Opin Lipidol. 2009;20:300\u20138.","journal-title":"Curr Opin Lipidol"},{"key":"409_CR60","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2458-14-14","volume":"14","author":"LL Roberson","year":"2014","unstructured":"Roberson LL, Aneni EC, Maziak W, Agatston A, Feldman T, Rouseff M, et al. Beyond BMI: the \u201cmetabolically healthy obese\u201d phenotype & its association with clinical\/subclinical cardiovascular disease and all-cause mortality \u2013 a systematic review. BMC Public Health. 2014;14:14.","journal-title":"BMC Public Health"},{"key":"409_CR61","doi-asserted-by":"crossref","first-page":"758","DOI":"10.7326\/0003-4819-159-11-201312030-00008","volume":"159","author":"CK Kramer","year":"2013","unstructured":"Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions?: a systematic review and meta-analysis. Ann Intern Med. 2013;159:758\u201369. Not all patients who are \u201cmetabolically healthy but obese\u201d are truly healthy.","journal-title":"Ann Intern Med"},{"key":"409_CR62","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1210\/jc.2005-0482","volume":"90","author":"AD Karelis","year":"2005","unstructured":"Karelis AD, Faraj M, Bastard JP, St-Pierre DH, Brochu M, Prud\u2019homme D, et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab. 2005;90:4145\u201350.","journal-title":"J Clin Endocrinol Metab"},{"key":"409_CR63","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.pcad.2013.10.003","volume":"56","author":"E Oliveros","year":"2014","unstructured":"Oliveros E, Somers VK, Sochor O, Goel K, Lopez-Jimenez F. The concept of normal weight obesity. Prog Cardiovasc Dis. 2014;56:426\u201333.","journal-title":"Prog Cardiovasc Dis"},{"key":"409_CR64","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0306-9877(02)00238-4","volume":"61","author":"MF McCarty","year":"2003","unstructured":"McCarty MF. A paradox resolved: the postprandial model of insulin resistance explains why gynoid adiposity appears to be protective. Med Hypotheses. 2003;61:173\u20136.","journal-title":"Med Hypotheses"},{"key":"409_CR65","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2042-6410-3-13","volume":"3","author":"K Karastergiou","year":"2012","unstructured":"Karastergiou K, Smith SR, Greenberg AS, Fried SK. Sex differences in human adipose tissues - the biology of pear shape. Biol Sex Differ. 2012;3:13.","journal-title":"Biol Sex Differ"},{"key":"409_CR66","doi-asserted-by":"crossref","first-page":"66","DOI":"10.47102\/annals-acadmedsg.V38N1p66","volume":"38","author":"S Low","year":"2009","unstructured":"Low S, Chin MC, Ma S, Heng D, Deurenberg-Yap M. Rationale for redefining obesity in Asians. Ann Acad Med Singap. 2009;38:66\u20139.","journal-title":"Ann Acad Med Singap"},{"key":"409_CR67","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1172\/JCI7901","volume":"105","author":"O Gavrilova","year":"2000","unstructured":"Gavrilova O, Marcus-Samuels B, Graham D, Kim JK, Shulman GI, Castle AL, et al. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest. 2000;105:271\u20138.","journal-title":"J Clin Invest"},{"key":"409_CR68","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1210\/jc.2003-030723","volume":"89","author":"H Bays","year":"2004","unstructured":"Bays H, Mandarino L, DeFronzo RA. Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J Clin Endocrinol Metab. 2004;89:463\u201378.","journal-title":"J Clin Endocrinol Metab"},{"key":"409_CR69","doi-asserted-by":"crossref","first-page":"e63623","DOI":"10.1371\/journal.pone.0063623","volume":"8","author":"R Waal de","year":"2013","unstructured":"de Waal R, Cohen K, Maartens G. Systematic review of antiretroviral-associated lipodystrophy: lipoatrophy, but not central fat gain, is an antiretroviral adverse drug reaction. PLoS One. 2013;8:e63623.","journal-title":"PLoS One"},{"key":"409_CR70","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1056\/NEJMoa033179","volume":"350","author":"S Klein","year":"2004","unstructured":"Klein S, Fontana L, Young VL, Coggan AR, Kilo C, Patterson BW, et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med. 2004;350:2549\u201357.","journal-title":"N Engl J Med"},{"key":"409_CR71","first-page":"672","volume":"13","author":"A Blum","year":"2011","unstructured":"Blum A, Simsolo C, Sirchan R, Haiek S. \u201cObesity paradox\u201d in chronic obstructive pulmonary disease. Isr Med Assoc J. 2011;13:672\u20135.","journal-title":"Isr Med Assoc J"},{"key":"409_CR72","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.amjcard.2010.03.078","volume":"106","author":"M Benderly","year":"2010","unstructured":"Benderly M, Boyko V, Goldbourt U. Relation of body mass index to mortality among men with coronary heart disease. Am J Cardiol. 2010;106:297\u2013304.","journal-title":"Am J Cardiol"},{"key":"409_CR73","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4065\/mcp.2009.0562","volume":"85","author":"PA McAuley","year":"2010","unstructured":"McAuley PA, Kokkinos PF, Oliveira RB, Emerson BT, Myers JN. Obesity paradox and cardiorespiratory fitness in 12,417 male veterans aged 40 to 70\u00a0years. Mayo Clin Proc. 2010;85:115\u201321.","journal-title":"Mayo Clin Proc"},{"key":"409_CR74","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.mayocp.2012.11.020","volume":"88","author":"CJ Lavie","year":"2013","unstructured":"Lavie CJ, Cahalin LP, Chase P, Myers J, Bensimhon D, Peberdy MA, et al. Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure. Mayo Clin Proc. 2013;88:251\u20138.","journal-title":"Mayo Clin Proc"},{"key":"409_CR75","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/eurjhf\/hfq159","volume":"13","author":"C Adamopoulos","year":"2011","unstructured":"Adamopoulos C, Meyer P, Desai RV, Karatzidou K, Ovalle F, White M, et al. Absence of obesity paradox in patients with chronic heart failure and diabetes mellitus: a propensity-matched study. Eur J Heart Fail. 2011;13:200\u20136.","journal-title":"Eur J Heart Fail"},{"key":"409_CR76","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1304501","volume":"370","author":"DK Tobias","year":"2014","unstructured":"Tobias DK, Pan A, Jackson CL, O'Reilly EJ, Ding EL, Willett WC, et al. Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med. 2014;370:233\u201344.","journal-title":"N Engl J Med"},{"key":"409_CR77","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/oby.2010.347","volume":"19","author":"CF Bellows","year":"2011","unstructured":"Bellows CF, Zhang Y, Simmons PJ, Khalsa AS, Kolonin MG. Influence of BMI on level of circulating progenitor cells. Obesity (Silver Spring). 2011;19:1722\u20136.","journal-title":"Obesity (Silver Spring)"},{"key":"409_CR78","doi-asserted-by":"crossref","first-page":"904682","DOI":"10.1155\/2009\/904682","volume":"2009","author":"K Kollar","year":"2009","unstructured":"Kollar K, Cook MM, Atkinson K, Brooke G. Molecular mechanisms involved in mesenchymal stem cell migration to the site of acute myocardial infarction. Int J Cell Biol. 2009;2009:904682.","journal-title":"Int J Cell Biol"},{"key":"409_CR79","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/hrt.2005.069799","volume":"92","author":"Y Wang","year":"2006","unstructured":"Wang Y, Johnsen HE, Mortensen S, Bindslev L, Ripa RS, Haack-Sorensen M, et al. Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Heart. 2006;92:768\u201374.","journal-title":"Heart"},{"key":"409_CR80","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/oby.20662","volume":"22","author":"Look AHEAD Research Group","year":"2014","unstructured":"Look AHEAD Research Group. Eight-year weight losses with an intensive lifestyle intervention: the look AHEAD study. Obesity (Silver Spring). 2014;22:5\u201313.","journal-title":"Obesity (Silver Spring)"},{"key":"409_CR81","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1212914","volume":"369","author":"RR Wing","year":"2013","unstructured":"Wing RR, Bolin P, Brancati FL, Bray GA, Clark JM, Coday M, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369:145\u201354.","journal-title":"N Engl J Med"},{"key":"409_CR82","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s11883-012-0288-2","volume":"14","author":"F Moustarah","year":"2012","unstructured":"Moustarah F, Gilbert A, Despres JP, Tchernof A. Impact of gastrointestinal surgery on cardiometabolic risk. Curr Atheroscler Rep. 2012;14:588\u201396.","journal-title":"Curr Atheroscler Rep"},{"key":"409_CR83","doi-asserted-by":"crossref","unstructured":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.","DOI":"10.1001\/jama.285.19.2486"},{"key":"409_CR84","doi-asserted-by":"crossref","unstructured":"Stone NJ, Robinson J, Lichtenstein AH, Bairey Merz CN, Lloyd-Jones DM, Blum CB, et al. 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013. doi: 10.1161\/01.cir.0000437738.63853.7a","DOI":"10.1161\/01.cir.0000437738.63853.7a"},{"key":"409_CR85","unstructured":"International Atherosclerosis Society. An International Atherosclerosis Society position paper: global recommendations for the management of dyslipidemia. Full report. 2013. http:\/\/www.athero.org\/download\/IASPPGuidelines_FullReport_20131011.pdf . Accessed 31 Jan 2014."}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-014-0409-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11883-014-0409-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-014-0409-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T12:27:22Z","timestamp":1689078442000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11883-014-0409-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,25]]},"references-count":85,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["409"],"URL":"https:\/\/doi.org\/10.1007\/s11883-014-0409-1","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,25]]},"article-number":"409"}}